More Positive Phase IIa Data May Have Vertex CF Drug On Registration Path

Biotech will seek to win approval in CF patients with G551D mutation, then demonstrate broader application within the disease.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet